iRadimed
IRMD
$44.70
Share price
1.94%
Change (1 day)
3.59%
Change (1 year)
Categories
EPS for iRadimed (IRMD)
EPS in 2023 (TTM): $1.16
According to iRadimed's latest financial reports the company's current EPS (TTM) is $1.16. In 2022 the company made an earnings per share (EPS) of $1.02 an increase over its 2021 EPS that were of $0.75.
EPS history for iRadimed from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $1.16 | 13.73% |
| 2022 | $1.02 | 36% |
| 2021 | $0.75 | 525% |
| 2020 | $0.12 | -86.05% |
| 2019 | $0.86 | 45.76% |
| 2018 | $0.59 | 1080% |
| 2017 | $0.05000 | -92.65% |
| 2016 | $0.68 | -1.45% |
| 2015 | $0.69 | 248.38% |
| 2014 | $0.20 | 6.51% |
| 2013 | $0.19 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | $2.35 | 102.59% | 🇺🇸 USA |
 NuVasive NUVA | $0.54 | -53.45% | 🇺🇸 USA |
 DexCom DXCM | $0.98 | -15.52% | 🇺🇸 USA |
 AtriCure ATRC | -$0.54 | -146.55% | 🇺🇸 USA |